Skip to main content

SYNJ2 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 3 and 68 bp deletion in exon 3.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (AB265359), expandable thumbnail
  • Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (AB265359), expandable thumbnail

Key facts

Cell type
HeLa
Species or organism
Human
Tissue
Cervix
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 3 and 68 bp deletion in exon 3

Alternative names

Recommended products

SYNJ2 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 3 and 68 bp deletion in exon 3.

Key facts

Cell type
HeLa
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 3 and 68 bp deletion in exon 3
Disease
Adenocarcinoma
Concentration
Loading...

Properties

Gene name
SYNJ2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium
DMEM (High Glucose) + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Synaptojanin 2 also known as SYNJ2 is a protein encoded by the SYNJ2 gene. It has a molecular mass of approximately 180 kDa. Synaptojanin 2 functions as a phosphoinositide phosphatase which helps dephosphorylate phosphatidylinositol 45-bisphosphate (PIP2) to phosphatidylinositol (PI). This affects the membrane dynamics and signal transduction. The expression of synaptojanin 2 occurs in various tissues with notable abundance in the brain and testis.

Biological function summary

Synaptojanin 2 plays an important role in synaptic vesicle trafficking and endocytosis. It can function as a part of protein complexes involved in these processes. The protein is involved in rearranging the actin cytoskeleton which impacts cellular shape and movement. Its activity influences synaptic transmission efficiency by controlling the cycle of synaptic vesicles particularly in the nervous system which reflects its high expression in the brain.

Pathways

Synaptojanin 2 is closely linked to the phosphatidylinositol signaling pathway and the endocytosis pathway. These pathways are important for cellular communication and nutrient uptake. Within these pathways synaptojanin 2 interacts with proteins like dynamin a GTPase that mediates membrane fission during endocytosis. Synaptojanin 2 also functions in relation to AP-2 a clathrin adaptor complex that plays a role in vesicle formation highlighting its participation in endocytic trafficking.

Associated diseases and disorders

Synaptojanin 2 relates to conditions such as cancer and neurodegenerative diseases. Overexpression or mutation of synaptojanin 2 associates with certain types of cancers including breast cancer potentially via disrupted signal transduction. It maintains a connection with proteins like PTEN a known tumor suppressor through its involvement in lipid signaling. In neurodegenerative diseases abnormal synaptojanin 2 function may impact neuronal health and is linked to diseases such as Alzheimer's disease. Defective phosphoinositide metabolism influences amyloid precursor protein processing implicating synaptojanin 2 in the pathology of these disorders.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (ab265359), expandable thumbnail

    Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (ab265359)

    Allele-2: 68 bp deletion in exon 3.

  • Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (ab265359), expandable thumbnail

    Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (ab265359)

    Allele-1: 14 bp deletion in exon 3.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com